France· FR:69241562
NIMENRIX, poudre et solvant pour solution injectable. Vaccin méningococcique conjugué des groupes A, C, W135 et Y
A medicinal product, registered in France by PFIZER EUROPE MA EEIG (BELGIQUE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Manufacturer
- PFIZER EUROPE MA EEIG (BELGIQUE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- June 3, 2026
Packs & prices · 1
1 priced- cip1334009222539301 flacon(s) en verre - 1 seringue(s) préremplie(s) en verre avec 2 aiguille(s)EUR 39.22
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bcda385f-351e-4601-916b-e35f122ea4c8 GET /v1/drugs/bcda385f-351e-4601-916b-e35f122ea4c8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69241562",
"date_amm": "2012-04-20",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/12/767",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant pour solution injectable",
"voies_administration": "intramusculaire",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about NIMENRIX.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.